SUBSTANTINATION OF VACINE-PROPHILACSIS AGAINST INFLUENZA IN CHILDREN OF EARLY AGE
https://doi.org/10.22627/2072-8107-2013-12-1-22-25
Abstract
Influenza is one of the most dangerous infection for children of early age. Vaccine-prophylactics against influenza is the most important way to confine the spreading of the infection and to localize epidemic outbreak among children. Modern vaccines have a high level of safety and efficacy. It allows to apply them during the first year of life. The WHO and ECDC point out the necessity of group and individual immunity development among children of different age groups. The authors demonstrated important role of immunization against influenza for the mother to enhance resistance to the infection in the child in the first months of its life.
References
1. Зайцев А.А. Грипп: диагностика и лечение / А.А. Зайцев, А.И. Синопальников // Русский медицинский журнал. — 2008. — № 22. — С. 1494—1496.
2. Малый В.П. Грипп: Пособие для врачей / В.П. Малый, М.Г. Романцов, Т.В. Сологуб. — СПб—Харьков, 2007. — С. 112.
3. ECDC scientific advice on seasonal influenza vaccination of children and pregnant women: ECDC Technical report/ Stockholm: ECDC. — 2012. — P. 68.
4. The US HHS and FDA Vaccine Adverse Event Reporting System. Available from: http://vaers.hhs.gov/index.
5. Бектимиров Т.А. Вакцинопрофилактика гриппа // Лечащий врач. — 2005. — № 9. — 44—46.
6. Киселев О.И. Грипп и другие респираторные вирусные инфекции: эпидемиология, профилактика, диагностика и терапия / О.И. Киселев, И.Г. Маринич, А.А. Соминина. — СПб, 2003. — С. 245.
7. Маринич И.Г. Социальные аспекты эпидемического процесса при гриппе и других острых респираторных заболеваниях в России: Отчет об исследовании / И.Г. Маринич, Л.С. Карпова, Е.А. Смородинцева. — ГУ НИИ РАМН. — 2009. — 112 с.
8. Centers for Disease Control and Prevention (CDC). Update: influenza activity-United States, September 28, 2008 — April 4, 2009, and composition of the 2009—10 influenza vaccine. MMWR Morb Mortal Wkly Rep. — 2009. — 58(14). — Р. 369—374.
9. Burden of seasonal influenza hospitalization in children, United States 2003 to 2008 / A. Bramley et al. // J. Pediatr. — 2010. — 157(5). — Р. 808—814.
10. Severe hospitalised 2009 pandemic influenza A(H1N1) cases in France, 1 July — 15 November 2009/ C. Fuhrman et al. // Euro Surveill. — 2010. — 15(2).
11. Risk factors for hospitalisation and poor outcome with pandemic A/ H1N1 influenza: United Kingdom first wave (May-September 2009) / J.S. Nguyen-Van-Tam et al. // Thorax. — 2010. — 65(7). — Р. 645— 651.
12. Surveillance of hospitalisations for 2009 pandemic influenza A(H1N1) in the Netherlands, 5 June — 31 December 2009 / T.M. van't Klooster et al. // Euro Surveill. — 2010. — 15(2).
13. Mortality from pandemic A/H1N1 2009 influenza in England: public health surveillance study / L.J. Donaldson et. al. // BMJ. — 2009. — 339. — Р. 5213.
14. Pebody R.G. Pandemic Influenza A (H1N1) 2009 and mortality in the United Kingdom: risk factors for death, April 2009 to March 2010 / R.G. Pebody, E.McLean, H. Zhao // Euro Surveill. — 2010. — 15(20).
15. Centers for Disease Control and Prevention (CDC). Update: influenza activity-United States, August 30, 2009 — January 9, 2010. MMWR Morb Mortal Wkly Rep 2010. — 59(2). — Р. 38—43.
16. Centers for Disease Control and Prevention (CDC). Surveillance for pediatric deaths associated with 2009 pandemic influenza A (H1N1) virus infection — United States, April-August 2009. MMWR Morb Mortal Wkly Rep 2009. — 58(34). — Р. 941—947.
17. Kamigaki T. Epidemiological characteristics and low case fatality rate of pandemic (H1N1) 2009 in Japan / T. Kamigaki, H. Oshitani // PLoS Curr. — 2009. — RRN. — Р. 1139.
18. Fatal cases of influenza a in childhood / B.F. Johnson et al. // PLoS One. — 2009. — 4(10). — Р. 7671.
19. Sachedina N. Paediatric mortality related to pandemic influenza A H1N1 infection in England: anobservational population-based study / N. Sachedina, L.J. Donaldson // Lancet. — 2010. — 376(9755). — Р. 1846—1852.
20. Influenza-associated deaths among children in the United States, 2003—2004 / N. Bhat et al. // N Engl J Med. — 2005. — 353(24). — Р. 2559—2567.
21. Nair H. Global incidence of severe acute lower respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis / Abstracts of the 2010 Options for the Control of Influenza VII Conference. — 2011.
22. The cost of influenza in Thailand / J.M. Simmerman et al. // Vaccine. — 2006. — № 24. — Р. 4417—26.
23. Incidence of influenza virus infection in early infancy: a prospective study in South Asia / E. Henkle et al. // Pediatr Infect Dis J. — 2011. — № 30. — Р. 170—173.
24. Influenza virus infections in infants / W.P. Glezen et al. // Pediatr Infect Dis J. — 1997. — № 16. — Р. 1065—1068.
25. Clinical and economic impact of influenza vaccination on healthy children aged 2—5 years / S. Esposito et al. // Vaccine. — 2006. — 24(5). — Р. 629—635.
26. Salleras L. Effectiveness of virosomal subunit influenza vaccine in preventing influenza-related illnesses and its social and economic consequences in children aged 3—14 years: a prospective cohort study / L. Salleras, A. Dominguez, T. Pumarolaetal // Vaccine. — 2006. — 24(44—46). — Р. 6638—6642.
27. Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomised controlled trial / A. Hoberman et al. // JAMA. — 2003. — 290(12). — Р. 1608—1616.
28. Мирошниченко В.В. Особенности гриппа у привитых и непривитых детей, госпитализированных в детский инфекционный стационар / В.В. Мирошниченко, О.К. Александрова, Л.В. Гусакова // Педиатрия и инфекции: Материалы XI конгресса детских инфекционистов. — М.: Ассоциация педиатров-инфекционистов. — 2012. — С. 54.
29. Safety and immunogenicity of AS03B adjuvanted split virion versus nonadjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study / C.S. Waddington et al. // BMJ. — 2010. — № 340. — Р. 2649.
30. Enhanced immunogenicity of seasonal influenza vaccines in young children using MF59 adjuvant / T. Vesikari et al. // Pediatr Infect Dis J. — 2009. — № 28. — Р. 563—571.
31. Oil-in-Water Emulsion Adjuvant with Influenza Vaccine in Young Children / T. Vesikari et al. // N Engl J Med. — 2011. — № 365. — Р. 1406—1416.
32. Отечественная инактивированная субъединичная вакцина «Гриппол плюс»: безопасность и эффективность у детей от 6 месяцев до 3 лет / В.В. Романенко и др. // Детские инфекции. — 2012. — №4. — С. 44—47.
33. Product catalogue [Internet]. Pune. India: Serum Institute of India Limited; 2010. NASOVAC™ Influenza vaccine (human, live attenuated) pandemic (HIN1) (freeze-dried) [cited 2011 May 9]. Available from: http://www.seruminstitute.com/content/products/ product_nasovac.htm. 6
34. Press Release [Internet]. AstraZeneca Global; 2010. European regulator backs nasal spray vaccine FLUENZ for the prevention of seasonal influenza in children [cited 2011 May 9]. Available from: http:// www.astrazeneca.com/Media/Pressreleases/Article/Europeanregulatorbacks-nasal-spray-vaccine-FLUENZ-for-the-prev.
35. Simister N.E. Placental transport of immunoglobulin G // Vaccine. — 2003. — № 21. — Р. 3365—3369.
36. Стефани Д.В. Клиническая иммунология и иммунопатология детского возраста / Д.В. Стефани, Ю.Е. Вельтищев // Руководство для врачей. — М.: Медицина. — 1996. — 384 с.
37. Englund J.A. Maternal immunization with Haemophilus influenzae type b vaccines in different populations / J.A. Englund, W.P. Glezen // Vaccine. — 2003. — № 21. — Р. 3455—3459.
38. Comparison of neutralising antibody assays for detection of antibody to influenza A/H3N2 viruses: an international collaborative study / I. Stephenson, R.G. Das, J.M. Wood, J.M. Katz // Vaccine. — 2007. — № 25. — Р. 4056—4063.
39. Reuman P.D. Effect of passive maternal antibody on influenza illness in children: a prospective study of influenza A in mother-infant pairs / P.D.Reuman, E.M. Ayoub, P.A.Small // Pediatr Infect Dis J. — 1987. — №6. — Р.398—403.
40. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010 / A.E. Fiore et al. // MMWR Recomm Rep. — 2010. — № 59. — Р. 1—62.
41. Trivalent inactivated influenza virus vaccine given to two-month-old children: an off season pilot study / E.B. Walter et al. // Pediatr Infect Dis J. — 2009. — № 28. — Р. 1099—1104.
42. Trivalent inactivated influenza vaccine (TIV) immunogenicity in children 6 through 23 months of age: do children of all ages respond equally? / E.B. Walter et al. // Vaccine. — 2010. — № 28. — Р. 4376—4383.
43. Safety and immunogenicity of trivalent inactivated influenza vaccine in infants: a randomized double-blind placebo-controlled study / J.A. Englund et al. // Pediatr Infect Dis J. — 2010. — № 29. — Р. 105—110.
44. Effectiveness of maternal influenza immunisation in mothers and infants / K. Zaman et al. // N Engl J Med. — 2008. — 359(15). — Р. 1555— 1564.
45. Maternal influenza vaccination and effect on influenza virus infection in young infants / A.A. Eick et al. // Arch Pediatr Adolesc Med. — 2011. — 165(2). — Р. 104—111.
46. Развитие в постнатальном периоде детей, рожденных от вакцинированных против гриппа беременных / А.П. Черданцев и др. // Ульяновский медико-биологический журнал. — 2012. — № 3. — С. 80—85.
Review
For citations:
Cherdantsev A.P. SUBSTANTINATION OF VACINE-PROPHILACSIS AGAINST INFLUENZA IN CHILDREN OF EARLY AGE. CHILDREN INFECTIONS. 2013;12(1):22-25. (In Russ.) https://doi.org/10.22627/2072-8107-2013-12-1-22-25
Views:
1093
Email this article 